达里多雷

Q3 Medicine Archives of Psychiatry Research Pub Date : 2022-10-20 DOI:10.20471/may.2022.58.02.14

Vjekoslav Peitl, Darko Vlahović

{"title":"达里多雷","authors":"Vjekoslav Peitl, Darko Vlahović","doi":"10.20471/may.2022.58.02.14","DOIUrl":null,"url":null,"abstract":"Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Daridorexant\",\"authors\":\"Vjekoslav Peitl, Darko Vlahović\",\"doi\":\"10.20471/may.2022.58.02.14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.\",\"PeriodicalId\":8294,\"journal\":{\"name\":\"Archives of Psychiatry Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Psychiatry Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20471/may.2022.58.02.14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Psychiatry Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20471/may.2022.58.02.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

Daridorexant属于一类被称为双食欲素受体（OX1R和OX2R）拮抗剂的药物。它通过阻断促觉醒神经肽食欲素的结合来实现其功能。这种新的机制被认为可以降低过度活跃的觉醒，正如我们目前所知，大多数其他失眠治疗方法都可以是镇静剂。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Daridorexant

Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊